Nvidia Earnings Spotlight Jensen Huangs Commentary on China and Trump Relations Could Move Markets BristolMyers Squibb BMY Draws Hedge Fund Attention with 425 Dividend Yield and AI Partnership UK Energy Bills Set to Rise 13 from July as New Cap Takes Effect Ferrari Shares Slide Following Unveiling of First Electric Vehicle the Luce IranUS Tensions Escalate Trump Rejects Counterproposal Tehran Vows Defiance Strait of Hormuz Chokepoint in Focus UK Exports to US Plunge 25 Following Trumps Liberation Day Tariffs Trade Deficit Emerges ONCY Q3 2025 Earnings WiderthanExpected Loss Amid Clinical Progress PENN Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Canaan Inc Q1 2026 Earnings Deep EPS Miss Signals Continued Headwinds ONE Gas Q1 2026 Earnings EPS Falls Short of Estimates as Operating Environment Challenges Persist Winnebago Q1 2026 Earnings Operational Discipline Drives EPS Surprise Amid Subdued Demand Federal Signal Corporation FSS Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Procter Gamble PG Edges Higher Amid Defensive Appeal Holds Near MidRange PGZ Experiences Modest Dip as It Tests Support Near 926 MGIC Investment MTG Slips Slightly as Mortgage Insurance Sector Faces Headwinds KTH Preferred Stock Edges Lower Amid Stable Trading FixedIncome Sentiment Holds Steady GigCapital7 Unit GIGGU Holds Steady at 994 as Market Digests SPAC Dynamics Apollo Global and Blackstone Reportedly Working on 36 Billion Debt Financing for Anthropic EXAS Q4 2025 Earnings Significant EPS Miss Raises Questions on Path to Profitability Twilio TWLO Slips 43 as Selling Pressure Intensifies Support at 172 in Focus Aterian Inc ATER Q3 2025 Earnings Strong EPS Beat Highlights Operational Efficiency Ryde Group RYDE Q2 2025 Earnings EPS Misses Estimates Shares Surge 947 Precigen Q1 2026 Earnings Narrowed Loss Exceeds Expectations as Stock Rises CARL Q1 2026 Earnings Personal Surgery Specialist Beats EPS Estimates Stock Rises QGEN Q1 2026 Earnings EPS Misses Estimates Yet Shares Rise 166 NRP Q1 2026 Earnings Solid EPS Performance Amid Quiet Market Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline